Using pulsed electric fields in cancer therapy

NewsGuard 100/100 Score

Pulsed electric fields are helping fight cancer, whether by inducing tumor cell death or by stimulating the immune system. A comprehensive overview of this developing field is published in the preview issue of Bioelectricity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The full-text article is available free on the Bioelectricity website at https://www.liebertpub.com/doi/full/10.1089/bioe.2018.0001.

Richard Nuccitelli, PhD, of Pulse Biosciences, Hayward, CA, discusses the different ways bioelectricity is being used to treat tumors in the article "Application of Pulsed Electric Fields to Cancer Therapy." Dr. Nuccitelli provides a clearly written description of the three main types of pulses and their uses. Pulses in the millisecond domain are typically used to facilitate the uptake of nucleic acids, such as plasmids, by cells. These can therefore be used to deliver genes encoding cancer-fighting proteins into tumor cells. Pulses in the microsecond domain allow small molecules, such as drugs, to cross the cell membrane significantly increasing the efficiency of the treatment. The very short pulses, in the nanosecond domain, can create millions of small pores in the cell membrane that by themselves affect cell signaling and cell function. This excellent review introduces readers to one of the most advanced of the many applications of bioelectricity to human health.

"The development and testing of pulsed electric field technology perfectly illustrate how research in bioelectricity leads to transformative biomedical approaches," says Dany Spencer Adams, Editor-in-Chief of Bioelectricity, from Tufts University, Medford, MA.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions